Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Blood|April 8, 2006
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Francesco Buccisano, et al.
British Journal of Haematology|October 2, 2014
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromesFabio Efficace, Gianluca Gaidano, Massimo Breccia, et al.
Life Science Alliance|October 14, 2022
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatmentGiuseppe Sconocchia, Giulia Lanzilli, Valeriana Cesarini, et al.
Cancer Medicine|May 26, 2017
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemiaCristina Santoro, Isabella Sperduti, Roberto Latagliata, et al.
Hematological Oncology|May 18, 2017
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent studyFrancesca Palandri, Mario Tiribelli, Giulia Benevolo, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 13, 2017
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric RegistryFlavia Mayer, Laura Faglioni, Nera Agabiti, et al.
Hemasphere|December 29, 2021
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working PartyJesse M Tettero, Sylvie Freeman, Veit Buecklein, et al.
Blood Advances|November 3, 2021
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocolFrancesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, et al.
Blood|January 14, 2018
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyGerrit J Schuurhuis, Michael Heuser, Sylvie Freeman, et al.
British Journal of Haematology|April 3, 2020
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre settingDiana Hanekamp, Alexander N Snel, Angèle Kelder, et al.
Pageof 15